{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:35:18Z","timestamp":1782815718643,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12904-015-0052-9","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T16:39:39Z","timestamp":1445963979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study"],"prefix":"10.1186","volume":"14","author":[{"given":"Yong Joo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yeon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghee Shiny","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah-Ram","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yup","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Klepstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"issue":"3","key":"52_CR1","first-page":"426","volume":"53","author":"R Gallagher","year":"2007","unstructured":"Gallagher R. Opioid-induced neurotoxicity. Canadian family physician Medecin de famille canadien. 2007;53(3):426\u20137. PubMed Pubmed Central PMCID: 1949075.","journal-title":"Canadian family physician Medecin de famille canadien"},{"key":"52_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0959-8049(97)10053-3","volume":"34","author":"S Mercadante","year":"1998","unstructured":"Mercadante S. Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer. 1998;34:627\u201331.","journal-title":"Eur J Cancer"},{"key":"52_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0885-3924(97)00020-1","volume":"14","author":"M Ashby","year":"1997","unstructured":"Ashby M. Plasma Morphine and Glucuronide (M3G and M6G) concentrations in hospice inpatients. J Pain Symptom Manag. 1997;14:157\u201367.","journal-title":"J Pain Symptom Manag"},{"issue":"10","key":"52_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s002280050003","volume":"55","author":"P Klepstad","year":"2000","unstructured":"Klepstad P, Kaasa S, Borchgrevink PC. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol. 2000;55(10):713\u20139. PubMed.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"52_CR5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1399-6576.1998.tb05378.x","volume":"42","author":"P Sjogren","year":"1998","unstructured":"Sjogren P, Thunedborg LP, Christrup L, Hansen SH, Franks J. Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories. Acta Anaesthesiol Scand. 1998;42(9):1070\u20135. PubMed.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"8","key":"52_CR6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/0269216303pm835oa","volume":"17","author":"P Klepstad","year":"2003","unstructured":"Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P, et al. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. Palliat Med. 2003;17(8):679\u201387. PubMed Epub 2003\/12\/26. eng.","journal-title":"Palliat Med"},{"issue":"1","key":"52_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0304-3959(94)00148-8","volume":"61","author":"PJ Tiseo","year":"1995","unstructured":"Tiseo PJ, Thaler HT, Lapin J, Inturrisi CE, Portenoy RK, Foley KM. Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain. 1995;61(1):47\u201354. PubMed.","journal-title":"Pain"},{"issue":"2","key":"52_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0885-3924(98)00043-8","volume":"16","author":"MM Wood","year":"1998","unstructured":"Wood MM, Ashby MA, Somogyi AA, Fleming BG. Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine. J Pain Symptom Manage. 1998;16(2):112\u201320. PubMed.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"52_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.36076\/ppj.2011\/14\/123","volume":"14","author":"PJ Christo","year":"2011","unstructured":"Christo PJ, Manchikanti L, Ruan X, Bottros M, Hansen H, Solanki DR, et al. Urine drug testing in chronic pain. Pain Physician. 2011;14(2):123\u201343. PubMed.","journal-title":"Pain Physician"},{"issue":"2 Suppl","key":"52_CR10","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.36076\/ppj.2008\/11\/S155","volume":"11","author":"L Manchikanti","year":"2008","unstructured":"Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility. Pain Physician. 2008;11(2 Suppl):S155\u201380. PubMed.","journal-title":"Pain Physician"},{"key":"52_CR11","doi-asserted-by":"crossref","unstructured":"Heiskanen T, Langel K, Gunnar T, Lillsunde P, Kalso EA. Opioid concentrations in oral fluid and plasma in cancer patients with pain. J Pain Symptom Manage. 2014;19. PubMed.","DOI":"10.1016\/j.jpainsymman.2014.09.004"},{"issue":"6","key":"52_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1034\/j.1399-6576.2003.00138.x","volume":"47","author":"P Klepstad","year":"2003","unstructured":"Klepstad P, Dale O, Kaasa S, Zahlsen K, Aamo T, Fayers P, et al. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiol Scand. 2003;47(6):725\u201331. PubMed Epub 2003\/06\/14. eng.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"52_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/FTD.0000000000000009","volume":"36","author":"S Gregori De","year":"2014","unstructured":"De Gregori S, Minella CE, De Gregori M, Tinelli C, Ranzani GN, Govoni S, et al. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain. Ther Drug Monit. 2014;36(3):335\u201344. PubMed.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"52_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","volume":"74","author":"CC Faura","year":"1998","unstructured":"Faura CC, Collins SL, Moore RA, McQuay HJ. Systematic review of factors affecting the ratios of morphine and its major metabolites. Pain. 1998;74(1):43\u201353. PubMed.","journal-title":"Pain"},{"issue":"3","key":"52_CR15","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1556-4029.2011.01703.x","volume":"56","author":"S Darke","year":"2011","unstructured":"Darke S, Duflou J, Torok M. Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999\u20132008. J Forensic Sci. 2011;56(3):690\u20133. PubMed.","journal-title":"J Forensic Sci"},{"issue":"1","key":"52_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0376-8716(97)00070-7","volume":"47","author":"S Darke","year":"1997","unstructured":"Darke S, Sunjic S, Zador D, Prolov T. A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug Alcohol Depend. 1997;47(1):45\u201353. PubMed.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"52_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.neuroscience.2009.10.011","volume":"165","author":"SS Lewis","year":"2010","unstructured":"Lewis SS, Hutchinson MR, Rezvani N, Loram LC, Zhang Y, Maier SF, et al. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4\/MD-2 and interleukin-1beta. Neuroscience. 2010;165(2):569\u201383. PubMed Pubmed Central PMCID: 2795035.","journal-title":"Neuroscience"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-015-0052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12904-015-0052-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-015-0052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T15:03:35Z","timestamp":1653404615000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-015-0052-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1186\/s12904-015-0052-9","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"article-number":"53"}}